Document ID: chunk:federal_register_of_legislation:F2024C00867:reg:3
Version: federal_register_of_legislation:F2024C00867
Segment Type: reg
Provision Reference: reg 3
Character Range: 55497–56494

3                                                                     for each therapeutic vaping substance or therapeutic vaping substance accessory in the kit that is menthol flavour, mint flavour or tobacco flavour—the flavour, as stated on the main label of the primary pack of the good

 (2) The information required by subsection (1) must:
           (a) be orientated in the same direction; and
           (b) for the information mentioned in items 1 and 2—be displayed in a text size of at least 3 mm; and
           (c) for all other text—be displayed in a text size of at least 1.5 mm.
 (3) The name of the good on the main label of the kit must be presented in a continuous, uninterrupted manner and not be broken up by additional words or images.
 (4) Where a therapeutic vaping kit contains a therapeutic vaping substance or a therapeutic vaping substance accessory that contains nicotine, the main label of the kit must contain a warning statement panel as specified in section 20.